TinyGemsBreaks – Vision Energy Corp. (VENG) Issues Corporate and Project Development Update

Vision Energy (OTC: VENG) has provided a corporate and project development update. Among the results for the fiscal year ended Dec. 31, 2022, the company highlighted its sale of VoltH2 Dutch Subsidiaries, resulting in $11.25 MM injection of cash from sale proceeds to paid in capital as part of stockholders’ equity, as well as the acquisition of Evolution Terminals B.V. inclusive of 14 H.A. In addition, Vision Energy highlighted further 2022 fiscal year accomplishments, including its engagement of Linde Engineering to accelerate engineering development, the securing of an additional 2 H.A. of land contiguous to existing 14 H.A., as well as expansion of its project management and development team. “Our investments in partnerships, coupled with our expanding development team and accelerated development process has proven to be effective in attracting new partners and expanding existing relationships,” said VENG Chief Executive Officer Andrew Hromyk.

To view the full press release, visit https://ibn.fm/pIwov

About Vision Energy Corp.

Vision Energy identifies energy commodities and focuses on originating and developing energy infrastructure projects and assets, which facilitates the energy transition through low-carbon energy solutions. The company leverages its experienced team with a vast proven track-record in site procurement, accelerating development permitting, facilities design, engineering studies and project management to deliver an efficient and method driven project development process. Vision pursues commercial relationships and operating partnerships with energy industry participants and off-takers seeking carbon abatement across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions whilst targeting an attractive investment yield, by utilizing and leveraging existing gas, power and logistics infrastructure to enable import and or distribution of reduced-carbon energy for domestic and global value chains. For more information about the company, visit www.VisionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to VENG are available in the company’s newsroom at https://ibn.fm/VENG

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork.

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic…

2 days ago

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present…

2 days ago

TinyGemsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Allocate Solar Project Revenue to Bitcoin Treasury Strategy

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has…

2 days ago

TinyGemsBreaks – ECGI Holdings Inc. (OTC: ECGI) Backs AI-Focused Startup TrueToForm in First Uplist Ventures Deal 

ECGI Holdings (OTC: ECGI), a diversified holding company targeting innovation-led sectors, announced that its investment…

4 days ago

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Relaunches FIVE RS EV for German Market with FPF Partnership

Mullen Automotive (NASDAQ: MULN) announced the relaunch of its ultra-high-performance Mullen FIVE RS EV Crossover, with…

4 days ago

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Increases Ownership of Bollinger Motors to 95%, Resolves Receivership

Mullen Automotive (NASDAQ: MULN) has acquired an additional 21% stake in Bollinger Motors, bringing its total…

5 days ago